Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes

May 13, 2016 updated by: Dr. Stephanie Wu, DPM, MS, Rosalind Franklin University of Medicine and Science

Efficacy of a Mild Compression Diabetic Sock Versus A Non- Compression Diabetic Sock in the Control of Lower Extremity Edema in Patients With Diabetes: A Randomized Controlled Trial

The purpose of this study is to determine whether a specially designed sock for people with diabetes and swelling in the legs can reduce the swelling, improve blood flow to the legs, and improve physical activity patterns of those individuals by providing mild compression to their legs.

Study Overview

Status

Completed

Conditions

Detailed Description

Peripheral arterial disease (PAD) is commonly associated with diabetes. Clinicians are often reluctant to apply compressive stockings to patients with diabetes and swollen legs due to fear of exacerbating the symptoms of PAD. The study sock is a newly formulated sock that offers mild compression (18-25mmHg). The sock is made especially for the diabetic patient who suffers from concomitant lower extremity edema.

Eighty patients with diabetes and lower extremity edema will be recruited. Upon ensuring enrollment criteria are met, baseline edema (as measured by circumference of foot, ankle and calf), ankle brachial index (ABI), skin perfusion pressure, and cutaneous fluid level (as measured by MoistureMeter) will be assessed. Subjects will then be provided four pairs of socks. Subjects will be randomized in a 1:1 distribution to receive either the mild compression diabetic socks or a standard diabetic sock. They will return for four weekly follow up visits.

Additionally a sub-set of 30 subjects will be monitored for changes in physical activity pre and post sock usage. Physical activity monitors will be used to assess daily physical activity for 48hrs prior to receiving the socks and after wearing the socks for four weeks an additional 48hrs will be monitored.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • North Chicago, Illinois, United States, 60064
        • Rosalind Franklin University Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female with lower extremity edema aged 18 or older with the ability and willingness to provide Informed consent
  • Patient's ankle-brachial systolic pressure index > 0.6 and toe-brachial index > 0.3
  • Patient is willing to participate in all procedures and follow up evaluations necessary to complete the study.
  • Patient has diabetes type 1 or type 2 confirmed by patient's primary care physician.

Exclusion Criteria:

  • Patients with active wound infection, or untreated osteomyelitis, gangrene
  • Patients with dementia, or impaired cognitive function that would prohibit study compliance
  • Patients with wide spread malignancy or systemically immuno-compromising disease
  • Patients who are unable or unwilling to participate in all procedures and follow up evaluations
  • Patient with deep and/or large ulcers that require copious bandaging and may affect efficacy of socks. Patients with superficial ulcers that only require a light dressing are not excluded. The ulcer, if present, must be superficial and cannot exhibit any clinical signs of infection
  • Patients with restless leg syndrome, Parkinson's disease, or other disease that will cause involuntary movement during microvascular assessment
  • Patients with severe edema or calf circumference greater than 24" or 46cm
  • Patients with severe lymphedema
  • Patients with edema that in the opinion of the investigator requires higher compression than the 18-25mmHg provided by the compression socks
  • Patients who are currently wearing compression hose. (Patients who have been prescribed compression hose but have not worn compression stockings for the past 6 months can be included in the study)
  • Patients unable to walk one hundred feet.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mild Compression Diabetic Sock
Diabetic socks that provide 18-25mm Hg of pressure to the lower extremities.
A diabetic sock that provides mild compression (18-25mm Hg) is to be worn everyday for four weeks
Other: Standard Diabetic Sock
A standard diabetic sock that is designed to limit foot ulcer formation, but does not provide compression to the leg.
A diabetic sock that is not designed to provide compression is to be worn everyday for four weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cutaneous Water Content
Time Frame: change from baseline after 4 weeks of sock usage
Cutaneous water content was measured non-invasively by tissue dielectric constant (MoistureMeter) at a single location: 2 inches distal and 2 inches lateral to the fibular head.
change from baseline after 4 weeks of sock usage
Calf Edema
Time Frame: change from baseline after 4 weeks of sock usage
The circumference of calf was measured by a tape measure.
change from baseline after 4 weeks of sock usage
Ankle Edema
Time Frame: change from baseline after 4 weeks of sock usage
The circumference of ankle was measured by a tape measure.
change from baseline after 4 weeks of sock usage
Toe Brachial Index
Time Frame: change from baseline after 4 weeks of sock usage
ratio of systolic blood pressure of toe relative to systolic blood pressure of arm
change from baseline after 4 weeks of sock usage
Ankle Brachial Index
Time Frame: change from baseline after 4 weeks of sock usage
ratio of systolic blood pressure of ankle relative to systolic blood pressure of arm
change from baseline after 4 weeks of sock usage
Foot Edema
Time Frame: change from baseline after 4 weeks of sock usage
The circumference of the foot was measured by a tape measure.
change from baseline after 4 weeks of sock usage
Microcirculation for Medial Calf
Time Frame: change from baseline after 4 weeks of sock usage
microcirculation as measured by skin perfusion pressure
change from baseline after 4 weeks of sock usage
Microcirculation for Lateral Calf
Time Frame: change from baseline after 4 weeks of sock usage
microcirculation as measured by skin perfusion pressure
change from baseline after 4 weeks of sock usage
Microcirculation for Dorsum of Foot
Time Frame: change from baseline after 4 weeks of sock usage
microcirculation as measured by skin perfusion pressure
change from baseline after 4 weeks of sock usage

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity Level
Time Frame: baseline and after four weeks of wearing the socks
Physical activity monitors will be used to assess physical activity patters of participants for 48 hours prior to initiating sock usage and for 48 hours after the participants have worn the socks for four weeks.
baseline and after four weeks of wearing the socks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie Wu, DPM, MS, Rosalind Franklin University of Medicine and Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

February 3, 2012

First Submitted That Met QC Criteria

February 7, 2012

First Posted (Estimate)

February 8, 2012

Study Record Updates

Last Update Posted (Estimate)

June 22, 2016

Last Update Submitted That Met QC Criteria

May 13, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ORT 112

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Edema

Clinical Trials on mild compression diabetic sock

3
Subscribe